BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31000693)

  • 1. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.
    Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C
    Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA 00312 Attenuates Cell Proliferation and Invasion and Promotes Apoptosis in Renal Cell Carcinoma via miR-34a-5p/ASS1 Axis.
    Zeng J; Li Y; Wang Y; Xie G; Feng Q; Yang Y; Feng J
    Oxid Med Cell Longev; 2020; 2020():5737289. PubMed ID: 32308805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
    Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.
    Wang K; Sun Y; Tao W; Fei X; Chang C
    Cancer Lett; 2017 May; 394():1-12. PubMed ID: 28089832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.
    Gong D; Sun Y; Guo C; Sheu TJ; Zhai W; Zheng J; Chang C
    Clin Transl Med; 2021 Mar; 11(3):e353. PubMed ID: 33783995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals.
    Zhai W; Li S; Zhang J; Chen Y; Ma J; Kong W; Gong D; Zheng J; Xue W; Xu Y
    Mol Cancer; 2018 Nov; 17(1):157. PubMed ID: 30419914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
    Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
    Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner.
    Huang Q; Sun Y; Zhai W; Ma X; Shen D; Du S; You B; Niu Y; Huang CP; Zhang X; Chang C
    Oncogene; 2020 Oct; 39(43):6677-6691. PubMed ID: 32943729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
    Guan Z; Li C; Fan J; He D; Li L
    Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
    Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
    Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2.
    Zhou B; Zheng P; Li Z; Li H; Wang X; Shi Z; Han Q
    Cell Cycle; 2018; 17(23):2644-2654. PubMed ID: 30488762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.
    Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C
    Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5.
    Zhang H; Li W; Gu W; Yan Y; Yao X; Zheng J
    Cell Prolif; 2019 Sep; 52(5):e12640. PubMed ID: 31250518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling.
    Liu G; Ouyang X; Sun Y; Xiao Y; You B; Gao Y; Yeh S; Li Y; Chang C
    Cell Death Differ; 2020 Dec; 27(12):3258-3272. PubMed ID: 32587378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
    Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
    Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
    Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
    Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
    Xiong F; Liu K; Zhang F; Sha K; Wang X; Guo X; Huang N
    Oncol Rep; 2016 May; 35(5):3000-8. PubMed ID: 26883716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.